DEFUSE 3:取栓术缩短住院时间、增加居家时间并改善居住状况
DEFUSE 3 试验评估卒中后 6 至 16 小时时间窗内血管内取栓对住院时长、90 天内居家时间及居住状况的影响。结果显示取栓组住院中位时间更短、居家时间更多,出院时、30 天及 90 天居住状况均更优。
要点
- 取栓组住院中位时间 6.5 天,显著短于药物组的 9.1 天。
- 取栓组 90 天内居家中位时间 55 天,显著多于药物组的 0 天。
- 取栓组在出院时、30 天及 90 天居住状况均更优。
核心结论
- 在卒中后 6 至 16 小时时间窗内行血管内取栓可缩短住院时间、增加居家时间并改善卒中后 90 天内的居住状况。
研究设计与样本
- DEFUSE 3 试验比较取栓组与药物治疗组的住院时长、90 天内居家时间及居住状况。
主要发现
- 住院中位时间取栓组 6.5 天(四分位距 3.7-9.3),药物组 9.1 天(四分位距 6.2-15.0),P<0.001。
- 90 天内居家中位时间取栓组 55 天(四分位距 0-83),药物组 0 天(四分位距 0-53),P<0.001。
- 取栓组在出院时、30 天及 90 天的居住状况均更优,P 均<0.001。
临床怎么用
- 对符合 DEFUSE 3 标准的延迟时间窗卒中患者,取栓术不仅改善功能结局,还可减少住院天数并提高居家生活比例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The DEFUSE 3 trial (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke) demonstrated that endovascular thrombectomy in the 6- to 16-hour time window improves functional outcomes of patients with evidence of salvageable tissue on baseline computed tomography or magnetic resonance imaging. The purpose of this study is to assess the effect of endovascular therapy on length of hospital stay, home-time during the first 3 months poststroke, and living situation poststroke in DEFUSE 3. Methods- Duration of hospital stay and home-time (number of days during the 90-day poststroke period that the patient resides in their own home or in that of a relative) were compared between treatment groups using the Wilcoxon rank-sum test. Patient living situation was assessed at discharge, 30 days, and 90 days on an ordinal 4-point scale (home, acute rehabilitation unit, institutionalized care, or hospice/death) and differences between groups were analyzed using the Cochran-Armitage trend test. Results- Median length of hospital stay was 9.1 (interquartile range, 6.2-15.0) days in the medical group versus 6.5 (interquartile range, 3.7-9.3) days in the endovascular group (P<0.001). Median home-time during the first 90 days after stroke was 0 (interquartile range, 0-53) days in the medical group versus 55 (interquartile range, 0-83) days in the endovascular group (P<0.001). The endovascular group had more favorable living situations at time of discharge (P<0.001), 30 days (P<0.001), and 90 days (P<0.001) poststroke. Conclusions- Endovascular thrombectomy resulted in reduced hospital stay, more home-time, and more desirable living situations in the 90 days after stroke. These results provide evidence that endovascular therapy in the delayed time window can improve quality of life for stroke patients and reduce healthcare costs. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT02586415.
引用
- Tate WJ, Polding LC, Kemp S, et al. Thrombectomy Results in Reduced Hospital Stay, More Home-Time, and More Favorable Living Situations in DEFUSE 3. Stroke. 2019. PMID: 31288666. doi:10.1161/STROKEAHA.119.025165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。